Related Experiment Videos
Calcification of the driving diaphragm in a total artificial heart
Insights
Mineralization of the diaphragm in a total artificial heart (TAH) can be life-threatening years after implantation. However, the TNS Brno VII TAH model minimizes risks, offering optimal athrombogenicity for patients awaiting cardiac transplantation.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Materials Science
Background:
- Mineralization of artificial heart diaphragms is a significant long-term complication.
- Understanding calcification patterns and thrombogenicity is crucial for patient outcomes.
Purpose of the Study:
- To analyze the implications of diaphragm mineralization in total artificial hearts (TAHs).
- To review mechanisms, risks, and prevention strategies for TAH calcification.
- To evaluate the TNS Brno VII model for improved safety and efficacy.
Main Methods:
- Analysis of calcification time, site, and individual patterns.
- Investigation of the relationship between mineralization and thrombogenicity.
- Review of mineralization mechanisms and associated risks.
- Evaluation of prevention strategies for TAH calcification.
Main Results:
- Diaphragm calcification poses a long-term risk to TAH recipients, but not within the first 2-3 months post-implantation.
- The TNS Brno VII model demonstrates optimal athrombogenicity, designed to prevent calcified microemboli detachment.
- This model represents an advancement in TAH technology for bridging patients to cardiac transplantation.
Conclusions:
- Diaphragm mineralization is a critical factor affecting long-term TAH survival.
- The TNS Brno VII offers a safer alternative by addressing calcification and thrombogenicity concerns.
- This Czechoslovakian TAH model shows promise as a life-saving bridge to cardiac transplantation.
Abstract:
The implications of mineralization on the diaphragm of a TAH were highlighted. The problem was discussed from the point of view of time and site of calcifying deposit formation, and individual patterns of calcification as well as the question of the relationship between mineralization processes and thrombogenicity were considered. Attention was likewise given to actual calcification with regard to its mechanism, and to the risks that the calcification process in an artificial heart pose to the organism. Next, the options to prevent mineralization were reviewed. The issue as analysed especially on the basis of results obtained in the Centre of the State Research project called "Assistance and Replacement of the Heart", Regional Institute of National Health in Brno, Department of Pathological Physiology. It was pointed out that diaphragm calcification can compromise the life of an individual after many years of surviving with an artificial heart. Still, the risk is zero within the first two or three months following artificial heart implantation. The fact was underlined that the last model of a Czechoslovak-made artificial heart, called TNS Brno VII, re-designed in an effort to prevent the breaking away of calcified microemboli from the diaphragm, features optimal athrombogenity. Thus, the clinical version of this brand-new Czechoslovak TAH can be regarded as the best model of an artificial heart to be implanted as a life-saving measure tiding the patient over a period before a cardiac transplantation can be performed.